Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination
Lin‐Lei Chen(Queen Mary Hospital), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Hoi‐Wah Tsoi(University of Hong Kong), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Vincent Chi‐Chung Cheng(Queen Mary Hospital), Daphne Pui-Ling Lau, Jonathan Daniel Ip(University of Hong Kong), Cyril Chik‐Yan Yip(Queen Mary Hospital), Charlotte Yee-Ki Choi(University of Hong Kong), Tak‐Lun Que(Tuen Mun Hospital), Jian‐Piao Cai(University of Hong Kong), Wan-Mui Chan(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Lu Lu(Huashan Hospital), Xiaojuan Zhang(Jiangnan University), Allen Wing‐Ho Chu(University of Hong Kong), Wing‐Kin To, Ruiqi Zhang(University of Hong Kong), Kwok‐Hung Chan(University of Hong Kong), Anthony Raymond Tam(University of Hong Kong)
Cited by 51
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k